Sumarago, Ria S.

HRN: 28-35-82  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2026
CEFUROXIME 500MG (TAB)
07/24/2026
07/31/2026
PO
500mg
BID X 7 Days
UTI, S/P NSVD
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines